The store will not work correctly when cookies are disabled.
((S)-1-Methyl-2-phenyl-ethyl)-prop-2-ynyl-carbamic acid 1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl ester
ID: ALA343006
PubChem CID: 10781420
Max Phase: Preclinical
Molecular Formula: C19H24N2O2
Molecular Weight: 312.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C#CCN(C(=O)OC1=CCN(C)CC1)[C@@H](C)Cc1ccccc1
Standard InChI: InChI=1S/C19H24N2O2/c1-4-12-21(16(2)15-17-8-6-5-7-9-17)19(22)23-18-10-13-20(3)14-11-18/h1,5-10,16H,11-15H2,2-3H3/t16-/m0/s1
Standard InChI Key: ZMFSNVTVGWCNRL-INIZCTEOSA-N
Molfile:
RDKit 2D
24 25 0 0 1 0 0 0 0 0999 V2000
2.5875 -0.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2792 0.4583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1875 -0.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4875 -0.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0917 -0.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3792 -0.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0875 -1.6167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5875 0.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0750 -0.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2792 -0.5792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1125 0.6833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1875 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4917 -1.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 0.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6417 0.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3792 -2.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8917 1.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1542 0.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6417 1.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1542 1.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6792 0.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6792 1.5833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0625 1.2875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 1 0
5 4 2 0
6 15 1 0
7 14 1 0
8 2 1 0
9 6 3 0
10 1 2 0
11 8 1 0
12 4 1 0
13 5 1 0
14 12 1 0
15 2 1 0
16 11 1 0
17 7 1 0
8 18 1 1
19 16 1 0
20 16 2 0
21 20 1 0
22 19 2 0
23 21 2 0
8 24 1 6
7 13 1 0
23 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.41 | Molecular Weight (Monoisotopic): 312.1838 | AlogP: 2.91 | #Rotatable Bonds: 5 |
Polar Surface Area: 32.78 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.81 | CX LogP: 2.62 | CX LogD: 2.06 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.78 | Np Likeness Score: -0.51 |
References
1. Flaherty P, Castagnoli K, Wang YX, Castagnoli N.. (1996) Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: potential prodrugs of (R)- and (S)-nordeprenyl., 39 (24): [PMID:8941389] [10.1021/jm960477e] |